M e d i c a r e M e d i c a i d C o m m e r c i al O th e r T h i r d P a r t i es F u l l - r i s k P art i a l - r i sk F u l l - r i s k P art i a l - r i sk C a p i t at i o n , n e t R i s k P o o l S et t l e m e n
Tuesday, May 12, 2026 2 min read
Key Takeaway: The article discusses various financial and operational aspects of AstraZeneca's strategies with Medicare and Medicaid. It highlights their risk management approaches, including full-risk and partial-risk models along with incentive management. However, it primarily focuses on cost management and operational metrics, indicating potential challenges. The projected financial outlook for the coming years appears uncertain due to high general and administrative expenses.
Financial metrics appear concerning with high general and administrative costs.
Unclear future profitability as there is a focus on managing multiple risk models.
Full Press Release Details
M e d i c a r e M e d i c a i d C o m m e r c i al O th e r T h i r d P a r t i es F u l l - r i s k P art i a l - r i sk F u l l - r i s k P art i a l - r i sk C a p i t at i o n , n e t R i s k P o o l S et t l e m e n t s & I n c e nt i v e s M a n a g e m e n t F e e I n c o me F e e - f or - s er v i c e, n e t O th e r In c o me
Gr o w a d i f f ere n ti a t ed p r o v i d er ne t w o rk B e nd t he c o s t c u r ve I n v e s t i n p a ti e n t p r o gr a m s , p re v en t i v e c a re and c are m a nageme nt Car e E na b le m e nt Care Par t ners
1 0.0% 1.0% 2.0% 3.0% 4.0% 5.0% 6.0% 7.0% 8.0% 9.0% - $50.0 $10 0 .0 $15 0 .0 $20 0 .0 $25 0 .0 G & A ( $ M ) G & A % o f R e v e n ue F Y 2 0 2 3 F Y 2 0 2 4 F Y 2 0 2 5 Q 1 2 0 2 5 Q 1 2 0 26